Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol for myocardial ischemia-reperfusion protection during pediatric open-heart ventricular septal defect surgery
ChiCTR-TRC-09000422Phase 4Completed
- Sponsor
- Department of Anesthesiology, Union Hospital, Wuhan
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esmolol in Ventricular Septal Defect (VSD) (2 arms), sponsored by Department of Anesthesiology, Union Hospital, Wuhan. Primary endpoints: CK-MB and cardiac troponin I. Started Nov 2007; status: completed.
02
Drugs
esmolol
03
Conditions
Ventricular Septal Defect (VSD)
Beyond the preview
Go deeper on ChiCTR-TRC-09000422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000422.